Labvax 3(22)-23
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Labvax 3(22)-23, covering 2024-05-21 to 2024-05-21. Get the full timeline:
Most recent: Clinical Trial Update: A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma [Phase 1, Phase 2]